Not yet recruiting
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
NCT07678593
- Conditions
- Advanced Solid Tumors Cancer, Pancreatic Ductal Adenocarcinoma, RAS Mutation
- Locations
-
- Concord Cancer Centre, Concord Repatriation General Hospital, Sydney Local Health District Concord, New South Wales, Australia
- Macquarie University / Clinical Trials Unit North Ryde, New South Wales, Australia
- The Queen Elizabeth Hospital Woodville South, South Australia, Australia
- Monash Health (Monash Medical Centre) Clayton, Victoria, Australia